BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $37,053,000 | +62.1% | 330,384 | -9.5% | 0.23% | -25.9% |
| Q3 2020 | $22,857,000 | -28.0% | 365,232 | -10.2% | 0.30% | +24.5% |
| Q2 2020 | $31,728,000 | -99.9% | 406,773 | 0.0% | 0.24% | +7.5% |
| Q1 2020 | $23,222,671,000 | -48.8% | 406,773 | -28.2% | 0.23% | -24.8% |
| Q4 2019 | $45,355,558,000 | +108938.3% | 566,166 | 0.0% | 0.30% | +4.5% |
| Q3 2019 | $41,596,000 | -22.1% | 566,166 | 0.0% | 0.29% | -21.0% |
| Q2 2019 | $53,406,000 | +17.8% | 566,166 | 0.0% | 0.37% | +14.3% |
| Q1 2019 | $45,321,000 | +48.5% | 566,166 | 0.0% | 0.32% | +24.4% |
| Q4 2018 | $30,522,000 | -30.9% | 566,166 | 0.0% | 0.26% | -18.6% |
| Q3 2018 | $44,194,000 | – | 566,166 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |